News Buzz: Ascendis Pharma A/S (NASDAQ:ASND), Merck & Co. Inc. (NYSE:MRK), RSP Permian, Inc. (NYSE:RSPP), ARM Holdings plc (NASDAQ:ARMH), Signal Genetics (NASDAQ:SGNL)

Ascendis Pharma A/S (NASDAQ:ASND) belongs to Healthcare sector. Its net profit margin is -54.50% and weekly performance is -9.24%. On last trading day company shares ended up $16.11. Ascendis Pharma A/S (NASDAQ:ASND) distance from 50-day simple moving average (SMA50) is -9.91%. On 18 May, Ascendis Pharma A/S (NASDAQ:ASND) announced financial results for the three months ended March 31, 2015. Ascendis Pharma reported a cash balance of approximately €153.5 million at March 31, 2015. On February 2, 2015, Ascendis Pharma announced the closing of its initial public offering, with net proceeds of approximately $111.5 million (or approximately €98.3 million at such date) after deducting underwriting discounts, commissions and estimated offering expenses.

Merck & Co. Inc. (NYSE:MRK) shares increased 0.83% in last trading session and ended the day at $59.46. MRK Gross Margin is 61.40% and its return on assets is 11.00%. Merck & Co. Inc. (NYSE:MRK) quarterly performance is 2.48%. On 22 May, Merck & Co. Inc. (NYSE:MRK) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending approval of KEYTRUDA (pembrolizumab), the company’s anti-PD-1 therapy, for the treatment of advanced (unresectable or metastatic) melanoma, as both first-line therapy and in previously treated patients.).

On 27 May, RSP Permian, Inc. (NYSE:RSPP) shares fell -0.04% and was closed at $28.43. RSP Permian, Inc. (NYSE:RSPP) year to date (YTD) performance is 13.09%. On 20 May, RSP Permian, Inc. (NYSE:RSPP) announced that its shareholders have elected Kenneth V. Huseman to the Company’s Board of Directors. Mr. Huseman will serve a three-year term, expiring in 2018, and will replace David Albin of Natural Gas Partners on the Board. RSP’s shareholders also re-elected Ted Collins, Jr. and Michael W. Wallace each for another three-year term.

ARM Holdings plc (NASDAQ:ARMH) ended the last trading day at $53.64. Company weekly volatility is calculated as 1.54% and price to cash ratio as 24.04. ARM Holdings plc (NASDAQ:ARMH) showed a weekly performance of 2.50%. BMO Capital Markets reissued their market perform rating on shares of ARM Holdings plc (NASDAQ:ARMH) in a research report released on Monday morning. BMO Capital Markets currently has a GBX 1,075 ($16.91) price objective on the stock.

Signal Genetics, Inc. (NASDAQ:SGNL) shares moved up 10.34% in last trading session and ended the day at $1.60. SGNL Gross Margin is 27.90% and its return on assets is -99.40%. Signal Genetics, Inc. (NASDAQ:SGNL) quarterly performance is -52.10%. Signal Genetics, Inc. (NASDAQ:SGNL) announced that Samuel D. Riccitelli, President and Chief Executive Officer of Signal, will present a corporate overview at the LD Micro Invitational on June 1, 2015.

Leave a Reply

Your email address will not be published. Required fields are marked *